Cirqle Biomedical

Organon head of research and development Sandra Milligan is optimistic about the road ahead in women’s health, but also believes changes are needed in investment, research and regulation to smooth th

The contraceptive market is one famously defined by its lack of innovation. Despite pioneering attempts by researchers to bring new contraceptive options to market – particularly efforts to develop a

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cidara Hopes For Early 2023 Approval Of